PT  - JOURNAL ARTICLE
AU  - Bridget Hilton
AU  - Daniel Wilson
AU  - Anne-Marie O’Connell
AU  - Dean Ironmonger
AU  - Justine K Rudkin
AU  - Naomi Allen
AU  - Isabel Oliver
AU  - David Wyllie
TI  - Incidence of Microbial Infections in English UK Biobank Participants: Comparison with the General Population
AID  - 10.1101/2020.03.18.20038281
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.18.20038281
4099  - http://medrxiv.org/content/early/2020/03/29/2020.03.18.20038281.short
4100  - http://medrxiv.org/content/early/2020/03/29/2020.03.18.20038281.full
AB  - Understanding the genetic and environmental risk factors for serious bacterial infections in ageing populations remains incomplete. Utilising the UK Biobank (UKB), a prospective cohort study of 500,000 adults aged 40-69 years at recruitment (2006-2010), could help address this.We assess the feasibility of linking an England-wide dataset of microbiological isolations to UKB participants, to enable characterisation of microbial infections within the UKB Cohort. Microbiological infections occurring in patients in England, as recorded in the Public Health England Second Generation Surveillance System (SGSS), were linked to UKB participants using pseudonymised identifiers. By January 2015, ascertainment of laboratory reports from UKB participants by SGSS was estimated at 98%. 4.5% of English UKB participants had a positive microbiological isolate in 2015. Half of UKB isolates came from 12 laboratories, and 70% from 21 laboratories. Incidence rate ratios for microbial isolation, which is indicative of serious infection, from the UKB cohort relative to the comparably aged general population ranged from 0.6 to 1, compatible with the previously described healthy participant bias in UKB.Data on microbial isolations can be linked to UKB participants from January 2015 onwards. This linked data would offer new opportunities for research into infectious disease in older individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSupported by Public Health England’s Pipeline Fund. D.J.W. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (Grant 101237/Z/13/Z). D.J.W. is supported by a Big Data Institute Robertson Fellowship.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesn/a